Evidence map›Paper›PMID 34880383›Full record

ArticleScientific reports2021

Persimmon-derived tannin has antiviral effects and reduces the severity of infection and transmission of SARS-CoV-2 in a Syrian hamster model.

Ryutaro Furukawa, Masahiro Kitabatake, Noriko Ouji-Sageshima, Yuki Suzuki, Akiyo Nakano, Yoko Matsumura, Ryuichi Nakano, Kei Kasahara, Kaoru Kubo, Shin-Ichi Kayano and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.2field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Article
  3. Effects of Persimmon (International journal of molecular sciences · 2023
    Article
  4. Article
  5. Rapid Virucidal Activity of JapaneseApplied and environmental microbiology · 2023
    Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Natural tannins as anti-SARS-CoV-2 compounds.International journal of biological sciences · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Ryutaro FurukawaDepartment of Immunology, Nara Medical University, Kashihara, Nara, 634-8521, Japan.
Masahiro KitabatakeDepartment of Immunology, Nara Medical University, Kashihara, Nara, 634-8521, Japan.
Noriko Ouji-SageshimaDepartment of Immunology, Nara Medical University, Kashihara, Nara, 634-8521, Japan.
Yuki SuzukiDepartment of Microbiology and Infectious Diseases, Nara Medical University, Kashihara, Nara, 634-8521, Japan.
Akiyo NakanoDepartment of Microbiology and Infectious Diseases, Nara Medical University, Kashihara, Nara, 634-8521, Japan.
Yoko MatsumuraDepartment of Immunology, Nara Medical University, Kashihara, Nara, 634-8521, Japan.
Ryuichi NakanoDepartment of Microbiology and Infectious Diseases, Nara Medical University, Kashihara, Nara, 634-8521, Japan.
Kei KasaharaCenter for Infectious Diseases, Nara Medical University, Kashihara, Nara, 634-8522, Japan.
Kaoru KuboLaboratory Animal Research Center, Nara Medical University, Kashihara, Nara, 634-8521, Japan.
Shin-Ichi KayanoDepartment of Health and Nutrition, Faculty of Health Science, Kio University, Kitakatsuragi-gun, Nara, 635-0832, Japan.
Hisakazu YanoDepartment of Microbiology and Infectious Diseases, Nara Medical University, Kashihara, Nara, 634-8521, Japan.
Toshihiro ItoDepartment of Immunology, Nara Medical University, Kashihara, Nara, 634-8521, Japan. toshi-ito@naramed-u.ac.jp.
Nara Medical University · JPKio University · JP

Funding

Japan Society for the Promotion of Science JP18K11148
6 · The paper itself

Abstract

Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly spread across the world. Inactivating the virus in saliva and the oral cavity represents a reasonable approach to prevent human-to-human transmission because the virus is easily transmitted through oral routes by dispersed saliva. Persimmon-derived tannin is a condensed type of tannin that has strong antioxidant and antimicrobial activity. In this study, we investigated the antiviral effects of persimmon-derived tannin against SARS-CoV-2 in both in vitro and in vivo models. We found that persimmon-derived tannin suppressed SARS-CoV-2 titers measured by plaque assay in vitro in a dose- and time-dependent manner. We then created a Syrian hamster model by inoculating SARS-CoV-2 into hamsters' mouths. Oral administration of persimmon-derived tannin dissolved in carboxymethyl cellulose before virus inoculation dramatically reduced the severity of pneumonia with lower virus titers compared with a control group inoculated with carboxymethyl cellulose alone. In addition, pre-administration of tannin to uninfected hamsters reduced hamster-to-hamster transmission of SARS-CoV-2 from a cohoused, infected donor cage mate. These data suggest that oral administration of persimmon-derived tannin may help reduce the severity of SARS-CoV-2 infection and transmission of the virus.

Indexed as

COVID-19 Drug TreatmentAdministration, OralAnimalsAntiviral AgentsCOVID-19CricetinaeDiospyrosDisease Models, AnimalInterleukin-1betaInterleukin-6LungMaleMesocricetusSARS-CoV-2Severity of Illness IndexTanninsAntiviral AgentsInterleukin-1betaInterleukin-6Tannins

Identifiers

PMID34880383
PMCPMC8654961
OpenAlexW4200241753

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.